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Abstract
Isolated pancreatic metastases from a non-pancreatic primary malignancy are very rare. Studies have shown that
resection of metastases is of proven benefit in some types of tumors. We report a case of 76-year-old Taiwanese
woman with rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and abdominoperineal resection
2 years ago presenting with an asymptomatic mass at the pancreatic tail on a routine follow up abdominal com-
puted tomography scan. The patient underwent distal pancreatectomy and splenectomy under the preoperative
impression of a primary pancreatic malignancy. Histological examination of the surgical specimen showed meta-
static adenocarcinoma. Immunohistochemical studies confirmed the diagnosis of pancreatic metastasis from rectal
adenocarcinoma. Postoperative chemotherapy in the form of oral capecitabine was given. The patient is alive and
disease free 12 months after the surgery. In a patient presenting with a pancreatic mass with history of a non-pan-
creatic malignancy, a differential diagnosis of pancreatic metastasis should be considered. Surgical resection of a
solitary pancreatic mass is justified not only to get the definitive diagnosis but also to improve the survival.
Background
The common sites of metastasis from colorectal adenocar-
cinoma are the liver, lung, and regional lymph nodes [1].
Colorectal adenocarcinoma, however, rarely metastasize to
the pancreas. Isolated pancreatic metastases from non-
pancreatic primary tumors are very rare, accounting for
approximately 2% of all pancreatic neoplasms [2]. Renal
cell carcinoma is the most common primary malignancy
to metastasize to the pancreas [3-5]. Studies have shown
that surgical resections of hepatic or lung metastases for
colorectal malignancy patients provide survival benefit [1].
However, the role of surgery for a solitary pancreatic
metastasis from colorectal adenocarcinoma has not yet
been defined because of the rarity of the condition. To the
best of our knowledge, very few colorectal malignancy
cases with pancreatic metastases are reported in the litera-
ture [3-7]. Herein, we report a case with primary rectal
adenocarcinoma with metachronous pancreatic metastasis
undergoing surgical resection and also conduct a substan-
tial review of the literature relevant to pancreatic metas-
tases from colorectal malignancy.
Case Presentation
A 76-year-old Taiwanese woman had undergone neoad-
juvant chemotherapy/radiotherapy and abdominoperi-
neal resection for rectal adenocarcinoma (stage IIIa;
pT3N0 M0 according to the 6th edition AJCC; Figure 1)
2 years ago. No post-operative adjuvant chemotherapy
or radiotherapy was administered to the patient. She
was relatively well postoperatively, without any evidence
of disease recurrence or associated symptoms until she
was incidentally found to have a mass in the pancreatic
tail on a routine follow up abdominal computed tomo-
graphy scan.
On admission, physical examination, hematogram and
biochemistry tests were unremarkable, except for a mid-
line operative scar and an end-colostomy. The carci-
noembryonic antigen level (2.16 ng/ml) was within
normal range. Abdominal computed tomography
revealed an ill-defined hypodense mass measuring 3.0 ×
1.6 cm in diameter at the pancreatic tail (Figure 2).
There was no evidence of local recurrence of rectal can-
cer, lymphadenopathy or distant metastasis. A primary
pancreatic malignancy was suspected, and the patient
underwent distal pancreatectomy with splenectomy.
Macroscopically, the cut surface of the pancreatic
mass demonstrated a whitish, firm, and infiltrating
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showed a moderately differentiated adenocarcinoma
with marked necrosis (Figure 3A) which was morpholo-
gically the same as the primary rectal adenocarcinoma.
Immunohistochemical studies showed the tumor cells
positive for CK-20 (Figure 3B) and CDX-2 (Figure 3C),
markers for colorectal adenocarcinoma, confirming the
final diagnosis of pancreatic metastasis from rectal
adenocarcinoma.
The postoperative course was uneventful except for
fever which developed 3 weeks after surgery. Abdominal
computed tomography revealed a fluid collection, 3 cm
in size near the pancreatic stump suggestive of intraab-
dominal abscess and the patient recovered with antibio-
tic treatment. Post operative chemotherapy in form of
oral capecitabine was given and the patient is alive and
disease free 12 months after surgery.
Conclusions
The incidence of pancreatic metastases in autopsy series
performed in patients with malignant neoplasms ranged
from 1.6-11% [8]. Renal cell carcinoma is the most com-
mon primary tumor, followed by lung cancer (adenocar-
cinoma and non-small cell lung carcinoma), lobular
breast carcinoma, and more rarely, gastric cancer, mela-
noma, and soft-tissue sarcoma [3,6-11]. Solitary metas-
tases to the pancreas occur even less frequently. Roland
et al reported that 27 out of 1,357 (2%) non-pancreatic
tumor patients had solitary pancreatic metastases, and
resections were performed in only 4 patients [12]. Nakeeb
at al showed that among 363 pancreatoduodenectomies
(239 performed for malignant periampullary diseases),
metastatic pancreatic tumors were identified in 6 cases
(1.65%) [13]. Faure et al examined 269 pancreatic resec-
tions and found solitary pancreatic metastases in 8 cases
(2.97%) [14]. In another study by Sperti et al,i s o l a t e d
pancreatic metastases were noted in 8 of 259 pancreatec-
tomies (3%) [3]. Colorectal adenocarcinoma, however,
was rarely identified to metastasize to the pancreas in
those studies. Table 1 summarizes the details of colorec-
tal adenocarcinoma cases with isolated metastasis to the
pancreas in the literature and only 8 rectal adenocarci-
noma cases including our patient were identified.
Clinical presentations of colorectal tumor patients
with isolated pancreatic metastases are quite different
from that of primary pancreatic malignancy patients
who frequently have abdominal pain, body weight loss,
and jaundice [7,12]. As shown in table 1, only 4 patients
(4/20, 20%) with pancreatic metastases presented
abdominal pain and 1 had body weight loss (1/20, 5%).
Six of 20 patients (30%) manifested jaundice which
might be related to tumor location at the pancreatic
head with mass effects [4,5,7,10,12,13,15-22]. Interest-
ingly, 6 of 11 patients (54.5%) with tumor location at
the pancreatic head did not present jaundice. However,
it was remarkable that up to 45% of patients (9/20) were
asymptomatic upon presentation. It was also reported
that imaging studies are unable to differentiate primary
pancreatic lesions from metastases by any specific man-
ners [23,24]. These observations and findings suggested
that if one had history of a non-pancreatic primary
malignancy presenting a pancreatic mass with unusual
manifestations during follow-up, solitary pancreatic
metastasis, in addition to primary pancreatic malig-
nancy, should be considered.
Figure 1 Histological specimen of primary rectal cancer
demonstrates a moderately-differentiated adenocarcinoma
with invading through the muscularis propria into the
subserosa (hematoxylin and eosin staining, 20×).
Figure 2 Abdominal computed tomography reveals an ill-
defined hypodense mass approximately 3.0 × 1.6 cm in
diameter in the pancreatic tail.
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Page 2 of 5Figure 3 Photomicrography of the pancreatic mass depicts a moderately differentiated adenocarcinoma with marked necrosis
(hematoxylin and eosin staining, 20×; A). Immunohistochemial stain studies of the pancreatic tumor shows positive for CK-20 (B) and CDX2
(C), further confirming the diagnosis of metastasis from rectal adenocarninoma.
Table 1 Clinical data of colorectal cancer patients with isolated pancreatic metastases undergoing pancreatic resection
in the literature
Authors Age
(years)
Sex Site of
primary
tumor
Interval between primary
tumor and metastases
(months)
Symptoms Site Pancreatic
surgery
Survival
(months)
Roland et al. [12] - F Colon - - Tail DP 27 ††
Nakeeb et al. [13] 39 M Colon 34 No Head Whipple 43 ††
Harrison et al. [15] - - Colon 15 - Head Whipple 41 †††
- - Colon 15 - Head Whipple 21 †††
Inagaki et al. [16] 79 M Rectum 132 No Body-tail DP 8 †
Le Borgne et al. [10] 50 M Colon 60 Jaundice Head Whipple 12 †††
Tutton et al. [17] 37 M Colon 23 No Tail DP 12 †
Torres-Villalobos et al. [18] 86 F Cecum 8 Body weight loss Body-tail- DP 6 †
Crippa et al. [5] 50 M Colon 7 No Head PPPD 13 †††
Matsubara et al. [19] 50- M Rectum 36 Jaundice Head Whipple 24 †††
Eidt et al. [20] - - Colon 12 - Head PPPD 105 †††
Shimada et al. [21] 54 M Rectum 44 No Head Whipple 8 †††
Bachmann et al. [22] 61 F Rectum 24 Abdominal pain Tail DP 2 †
64 F Rectum 30 No Body-tail DP 10 †
Reddy et al.* [4] - - Colon - - - - 3.2 yr**
Sperti et al. [7] 62 M Colon 48 Jaundice Head Whipple 31 †
71 M Colon 0 (synchronous) Jaundice Head PPPD 28 †
59 M Colon 10 Jaundice Head Whipple 17 †††
62 F Colon 36 Abdominal pain Tail DP 14 †
41 F Colon 24 Abdominal pain Head PPPD 10 †††
76 F Colon 0 (synchronous) Abdominal pain Head PPPD 15 †††
77 F Colon 0 (synchronous) No Body DP 5 †††
48 M Rectum 29 No Tail DP 30 ††
57 M Rectum 80 Jaundice Head
Tail
Enucleation
DP
24 †††
Present case 76 F Rectum 24 No Tail DP 12 †
-, not available; *, two cases with colon cancer; **, median cumulative survival of two cases; †, alive; ††; alive with disease;
†††, dead; DP, distal pancreatectomy; PPPD, pylorus-preserving pancreatoduodenectomy
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lated distant organ metastasis and the absence of wide-
spread diseases, a number of studies have shown that
resection of metastases has been proven beneficial for
some types of tumors. For example, metastases to the
liver, brain, and lung from tumors such as sarcoma,
renal cell carcinoma, colorectal cancer, and gastrointest-
inal stromal tumors, metastasectomy have been reported
to have salutary effects on patient survival [1,25-28].
However the role of surgery for solitary pancreatic
metastases from colorectal carcinoma has not yet been
well-defined. Given the fact that metastasectomies for col-
orectal cancer patients with hepatic and pulmonary metas-
tases are beneficial [1,25], it seems to be reasonable to
perform pancreatic resections for those patients with iso-
lated pancreatic metastases. Table 1 demonstrated out-
comes of patients after pancreatic resections for metastatic
colorectal adenocarcinoma with median survival of 16.5
months. Notably, Reddy et al reported that a cumulative
median survival of patients after pancreatic resection was
more than 3 years [4]. In the current case, surgical resec-
tion is reasonable to treat and get the definite diagnosis as
well as to improve patient survival. Our patient is alive
with disease free more than 12 months after distal pan-
createctomy and splenectomy. From a review of surgical
outcomes of previously reported cases including our
patient and less than 5% of surgical mortality rate in pan-
creatic surgery [29], we suggest that pancreatic resection
for a solitary pancreatic metastasis from colorectal carci-
noma is safe and feasible in a center with high volume of
pancreatic surgery. The role of postoperative adjuvant
therapy still remains controversial, and further studies are
needed to clarify this issue.
Pancreatic metastases should be kept in mind when a
patient with history of a non-pancreatic malignancy, such
as colorectal adenocarcinoma presenting a pancreatic
mass. Long-term follow-up with appropriate imaging stu-
dies is mandatory to detect the distant metastasis includ-
ing the pancreas. Pancreatic resection for an isolated
pancreatic metastasis from colorectal adenocarcinoma is
feasible in selected cases. Surgical resection of a solitary
pancreatic mass is justified not only to get the definitive
diagnosis but also to improve the survival.
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